GlassScriptPhysician profile
Seema S Gupta
NPI 1497861470
$3,495.02
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,266 · 2020: $608 · 2021: $1,239 · 2022: $382.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,246.51 | 2019-2022 | |
| Abbvie INC. | $814.39 | 2019-2025 | |
| Lilly USA, LLC | $409.52 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $383.91 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $258.07 | 2019 | |
| Amgen INC. | $113.39 | 2019 | |
| Novo Nordisk INC | $99.76 | 2020-2021 | |
| Allergan, INC. | $50.30 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $28.15 | 2022 | |
| Nestle Healthcare Nutrition INC. | $26.43 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $24.31 | 2021 | |
| Sanofi Pasteur INC. | $14.41 | 2020 | |
| Alfasigma USA, INC. | $13.05 | 2021 | |
| Horizon Therapeutics Plc | $12.82 | 2020 |
Research and ownership
$272.46 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seema Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.